1. Home
  2. HUBC vs TENX Comparison

HUBC vs TENX Comparison

Compare HUBC & TENX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • HUBC
  • TENX
  • Stock Information
  • Founded
  • HUBC 2017
  • TENX 1967
  • Country
  • HUBC Israel
  • TENX United States
  • Employees
  • HUBC N/A
  • TENX N/A
  • Industry
  • HUBC
  • TENX Biotechnology: Pharmaceutical Preparations
  • Sector
  • HUBC
  • TENX Health Care
  • Exchange
  • HUBC Nasdaq
  • TENX Nasdaq
  • Market Cap
  • HUBC 21.7M
  • TENX 21.7M
  • IPO Year
  • HUBC N/A
  • TENX N/A
  • Fundamental
  • Price
  • HUBC $2.66
  • TENX $5.46
  • Analyst Decision
  • HUBC
  • TENX Strong Buy
  • Analyst Count
  • HUBC 0
  • TENX 3
  • Target Price
  • HUBC N/A
  • TENX $16.00
  • AVG Volume (30 Days)
  • HUBC 389.6K
  • TENX 18.4K
  • Earning Date
  • HUBC 12-13-2024
  • TENX 05-13-2025
  • Dividend Yield
  • HUBC N/A
  • TENX N/A
  • EPS Growth
  • HUBC N/A
  • TENX N/A
  • EPS
  • HUBC N/A
  • TENX N/A
  • Revenue
  • HUBC $33,357,000.00
  • TENX N/A
  • Revenue This Year
  • HUBC N/A
  • TENX N/A
  • Revenue Next Year
  • HUBC N/A
  • TENX N/A
  • P/E Ratio
  • HUBC N/A
  • TENX N/A
  • Revenue Growth
  • HUBC N/A
  • TENX N/A
  • 52 Week Low
  • HUBC $2.43
  • TENX $2.77
  • 52 Week High
  • HUBC $14.00
  • TENX $7.89
  • Technical
  • Relative Strength Index (RSI)
  • HUBC 36.64
  • TENX 42.57
  • Support Level
  • HUBC $2.86
  • TENX $4.63
  • Resistance Level
  • HUBC $3.02
  • TENX $5.75
  • Average True Range (ATR)
  • HUBC 0.38
  • TENX 0.42
  • MACD
  • HUBC 0.07
  • TENX -0.04
  • Stochastic Oscillator
  • HUBC 16.20
  • TENX 47.70

About HUBC Hub Cyber Security Ltd.

Hub Cyber Security Ltd is engaged in the development of cyber products, software, quality systems, reliability, and risk management. It operates in several countries and provides cybersecurity computing appliances as well as a wide range of cybersecurity professional services. The company has two operating segments: the Product and Technology Segment, and the Professional Services Segment. The majority of its revenue comes from the professional services segment, which provides data and cybersecurity, system security and reliability solutions, as well as related services such as consulting, planning, training, integration, and ongoing servicing of cybersecurity, risk management, system quality, reliability, and security projects, including fully managed corporate cybersecurity services.

About TENX Tenax Therapeutics Inc.

Tenax Therapeutics Inc is a specialty pharmaceutical company focused on identifying, developing, and commercializing products that address cardiovascular and pulmonary diseases with high unmet medical needs. The company owns North American rights to develop and commercialize levosimendan and has released topline data regarding the Phase 2 clinical trial for the use of levosimendan in the treatment of pulmonary hypertension associated with Heart Failure and preserved Ejection Fraction.

Share on Social Networks: